| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |